Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP-binding cassette sub-family G member 2 (ABCG2) is a critical plasma membrane efflux transporter that belongs to the ATP-binding cassette (ABC) superfamily. Unlike many other ABC transporters, ABCG2 is a "half-transporter" that must form homodimers or higher-order oligomers to become functionally active. It is highly expressed in the apical membranes of the epithelium in the small intestine, liver canalicular membrane, and kidney proximal tubules, as well as in the endothelial cells of the blood-brain barrier and the syncytiotrophoblasts of the placenta. Its primary biological role is the protection of the body against xenobiotic toxins by limiting their absorption and promoting their excretion.
In the context of oncology, ABCG2 is frequently overexpressed in various cancer types, where it contributes significantly to multidrug resistance (MDR) by actively pumping out chemotherapeutic agents such as mitoxantrone and topotecan. Furthermore, ABCG2 is a high-capacity urate exporter; genetic variants like the Q141K polymorphism significantly reduce its transport activity, leading to hyperuricemia and an increased risk of gout. Due to its broad substrate specificity, ABCG2 is a major determinant of the pharmacokinetics and toxicity profiles of numerous drugs, making it a focal point for regulatory drug-drug interaction studies.
ATP-dependent efflux transporter that pumps substrates out of the cytoplasm or cell membrane to the extracellular space, thereby reducing intracellular drug accumulation and mediating resistance.
11 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP-binding cassette sub-family G member 2 (ABCG2) (ABCG2).